Oxadiazoleand oxazole-substituted benzimidazoleand indole-derivatives as DGAT1 inhibitors

Details for Australian Patent Application No. 2008303541 (hide)

Owner Novartis AG

Inventors Coppola, Gary Mark; Kwak, YoungShin

Agent Davies Collison Cave

Pub. Number AU-B-2008303541

PCT Pub. Number WO2009/040410

Priority 60/976,064 28.09.07 US

Filing date 26 September 2008

Wipo publication date 2 April 2009

Acceptance publication date 7 June 2012

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/040410 Priority application(s): WO2009/040410

7 June 2012 Application Accepted

  Published as AU-B-2008303541

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303547-Clamping lock for a tensioning means

2008303540-Drug monitoring assay